These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22823129)

  • 1. Pharmacophore models for GABA(A) modulators: implications in CNS drug discovery.
    Ghoshal N; Vijayan RS
    Expert Opin Drug Discov; 2010 May; 5(5):441-60. PubMed ID: 22823129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-based virtual screening: a review of recent applications.
    Kim KH; Kim ND; Seong BL
    Expert Opin Drug Discov; 2010 Mar; 5(3):205-22. PubMed ID: 22823018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When analoging is not enough: scaffold discovery in medicinal chemistry.
    Zhao H; Akritopoulou-Zanze I
    Expert Opin Drug Discov; 2010 Feb; 5(2):123-34. PubMed ID: 22822912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of estrogen receptor modulators: a review of virtual screening and SAR efforts.
    Xu X; Yang W; Li Y; Wang Y
    Expert Opin Drug Discov; 2010 Jan; 5(1):21-31. PubMed ID: 22823969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore modelling: applications in drug discovery.
    Langer T; Hoffmann RD
    Expert Opin Drug Discov; 2006 Aug; 1(3):261-7. PubMed ID: 23495846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery.
    Shin WJ; Seong BL
    Expert Opin Drug Discov; 2013 Apr; 8(4):411-26. PubMed ID: 23373617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GRID/CPCA approach in drug discovery.
    Rocha JR; Freitas RF; Montanari CA
    Expert Opin Drug Discov; 2010 Apr; 5(4):333-46. PubMed ID: 22823086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
    Yang SY
    Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Development of Pharmacophore Modeling: Generation and Recent Applications in Drug Discovery.
    Lu X; Yang H; Chen Y; Li Q; He SY; Jiang X; Feng F; Qu W; Sun H
    Curr Pharm Des; 2018; 24(29):3424-3439. PubMed ID: 30101699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacophores in Drug Research.
    Langer T
    Mol Inform; 2010 Jul; 29(6-7):470-5. PubMed ID: 27463325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational systems approach for drug target discovery.
    Chandra N
    Expert Opin Drug Discov; 2009 Dec; 4(12):1221-36. PubMed ID: 23480463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel GABA(B) receptor positive modulators: a patent survey.
    Froestl W
    Expert Opin Ther Pat; 2010 Aug; 20(8):1007-17. PubMed ID: 20645682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
    Vijayan RS; Ghoshal N
    J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.
    Franco R; Canela EI; Casado V; Ferre S
    Expert Opin Drug Discov; 2010 Apr; 5(4):391-403. PubMed ID: 22823089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for computational screening of non-steroidal androgen receptor ligands.
    Nyrönen TH; Söderholm AA
    Expert Opin Drug Discov; 2010 Jan; 5(1):5-20. PubMed ID: 22823968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of chemical libraries for screening.
    Villar HO; Hansen MR
    Expert Opin Drug Discov; 2009 Dec; 4(12):1215-20. PubMed ID: 23480462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.